PULSE the living trend engine
🤖 Open Intelligence Dossier available for AI agents & citation View Markdown (.md) →
▲ Peaking Health

Keto diet slashes liver fat by 67% in just 4 months

A small clinical trial reports a 67% reduction in liver fat after four months on a ketogenic diet, drawing coverage from five outlets.

5sources
5articles
3velocity
+40%since first seen
2h agofirst detected

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The brief

Coverage from BGNES, JournalArta, UA.NEWS, Men's Fitness, and ScienceDaily reports that a ketogenic diet cut liver fat by 67% over a four-month period in a clinical trial. The headlines identify the intervention as a ketogenic diet and the outcome as a 67% reduction in liver fat measured after four months. The sources describe the trial as small, though the coverage does not specify the exact number of participants, the trial's phase, the primary endpoints beyond liver fat reduction, or the institutional sponsorship. All five articles carry the same timestamp of 2026-11-20 12:47 UTC, indicating simultaneous publication across the outlets. The coverage does not provide details on participant demographics, inclusion criteria, control group design, dietary adherence monitoring, or adverse events observed during the trial period.

The emphasis across outlets centers on the magnitude of the reported liver fat reduction and the relatively short four-month duration. ScienceDaily and Men's Fitness frame the finding in the context of fatty liver disease, while BGNES, JournalArta, and UA.NEWS present the result as a direct outcome of the ketogenic diet intervention. None of the headlines reference peer-reviewed publication status, journal name, or DOI. The coverage does not indicate whether the results were presented at a conference, posted as a preprint, or released via institutional press release. No outlet quotes investigators, and no independent expert commentary is cited in the headlines provided.

Background context includes growing research interest in dietary interventions for non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD). Ketogenic diets have been studied for weight loss, glycemic control, and lipid metabolism, but large-scale, long-term randomized controlled trials specifically powered for liver fat endpoints remain limited. The 67% figure, if confirmed in larger cohorts, would represent a substantial effect size compared with lifestyle interventions typically reported in the literature. However, the coverage does not establish how liver fat was quantified (e.g., MRI-PDFF, MRS, biopsy), whether the reduction is absolute or relative, or how it compares with control groups receiving standard care or alternative diets.

What to watch next includes the release of the full trial manuscript, peer-review status, and replication in larger, more diverse populations. Regulatory and clinical guideline bodies typically require confirmatory evidence before recommending specific dietary protocols for liver disease. Coverage does not indicate planned follow-up studies, extension phases, or mechanistic sub-studies. Readers should monitor major hepatology and nutrition journals for the primary publication and subsequent systematic reviews that may contextualize this result within the broader evidence base.

Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 47m ago.

Quick answers

What was the size and design of the clinical trial?

The coverage describes the trial as small but does not specify the number of participants, randomization scheme, control group, or blinding procedures.

How was liver fat measured in the study?

The headlines do not state the imaging or biopsy method used to quantify liver fat (e.g., MRI-PDFF, magnetic resonance spectroscopy, histology).

Has the study been peer-reviewed and published in a journal?

The coverage does not mention a journal name, publication date, DOI, or peer-review status; it only notes simultaneous article timestamps across five outlets.

Coverage (5)

Topics

Related trends

◼ Archived Health

Trying Tourette's device was the best day of my life

A wrist-worn nerve-stimulation device developed at the University of Nottingham cut tic frequency by 25% in a 121-person trial and users describe the effect as instant and life-changing.

7 sources 7 articles v 5 2d ago